Published on
May 26, 2021
- 12:05 GMT
Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel biosynthesis pathway
MONTREAL, QUEBEC, CANADA, May 26, 2021 /EINPresswire.com/ -- Hyasynth, a sustainable biotechnology company specializing in fermentation-produced cannabinoid ingredients, today announced an update on its biosynthesis process and patent portfolio. On April …
